| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6010364 | Epilepsy & Behavior | 2015 | 5 Pages |
Abstract
Patients who initiated generic AEDs had fewer adverse seizure-related clinical outcomes and longer continuous treatment periods before experiencing a gap than those who initiated brand-name versions.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Joshua J. Gagne, Aaron S. Kesselheim, Niteesh K. Choudhry, Jennifer M. Polinski, David Hutchins, Olga S. Matlin, Troyen A. Brennan, Jerry Avorn, William H. Shrank,